Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Richard Law downgraded MoonLake Immunotherapeutics (NASDAQ:MLTX) from Neutral to Sell and raised the price target from $8 to $10. MoonLake shares closed at $17.41 on Wednesday. See how other analysts view this stock.
- Morgan Stanley analyst Simeon Gutman downgraded Leslie’s Inc (NASDAQ:LESL) from Equal-Weight to Underweight and cut the price target from $3.5 to $1.5. Leslies shares closed at $1.54 on Wednesday. See how other analysts view this stock.
- Keybanc analyst Michael Leshock downgraded Rocket Lab Corp (NASDAQ:RKLB) from Overweight to Sector Weight. Rocket Lab shares closed at $91.80 on Wednesday. See how other analysts view this stock.
- Morgan Stanley analyst Simeon Gutman downgraded Albertsons Companies Inc (NYSE:ACI) from Equal-Weight to Underweight and lowered the price target from $20 to $14. Albertsons shares closed at $17.71 on Wednesday. See how other analysts view this stock.
Considering buying RKLB stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments